N

NRX Pharmaceuticals
D

NRXP

3.53000
USD
0.03
(0.86%)
قبل الجلسة·3.51000USD-0.02000(-0.57%)
حجم التداول
23,574
الربح لكل سهم
-0
العائد الربحي
-
P/E
-7
حجم السوق
152,834,058
أصول ذات صلة المقالات
المزيد

العنوان: NRX Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.